348 related articles for article (PubMed ID: 24405868)
1. The novel p.Cys65Tyr mutation in NR5A1 gene in three 46,XY siblings with normal testosterone levels and their mother with primary ovarian insufficiency.
Fabbri HC; de Andrade JG; Soardi FC; de Calais FL; Petroli RJ; Maciel-Guerra AT; Guerra-Júnior G; de Mello MP
BMC Med Genet; 2014 Jan; 15():7. PubMed ID: 24405868
[TBL] [Abstract][Full Text] [Related]
2. Screening and familial characterization of copy-number variations in NR5A1 in 46,XY disorders of sex development and premature ovarian failure.
Harrison SM; Campbell IM; Keays M; Granberg CF; Villanueva C; Tannin G; Zinn AR; Castrillon DH; Shaw CA; Stankiewicz P; Baker LA
Am J Med Genet A; 2013 Oct; 161A(10):2487-94. PubMed ID: 23918653
[TBL] [Abstract][Full Text] [Related]
3. Wide spectrum of NR5A1-related phenotypes in 46,XY and 46,XX individuals.
Domenice S; Machado AZ; Ferreira FM; Ferraz-de-Souza B; Lerario AM; Lin L; Nishi MY; Gomes NL; da Silva TE; Silva RB; Correa RV; Montenegro LR; Narciso A; Costa EM; Achermann JC; Mendonca BB
Birth Defects Res C Embryo Today; 2016 Dec; 108(4):309-320. PubMed ID: 28033660
[TBL] [Abstract][Full Text] [Related]
4. Update--steroidogenic factor 1 (SF-1, NR5A1).
Köhler B; Achermann JC
Minerva Endocrinol; 2010 Jun; 35(2):73-86. PubMed ID: 20595937
[TBL] [Abstract][Full Text] [Related]
5. Testosterone production during puberty in two 46,XY patients with disorders of sex development and novel NR5A1 (SF-1) mutations.
Tantawy S; Lin L; Akkurt I; Borck G; Klingmüller D; Hauffa BP; Krude H; Biebermann H; Achermann JC; Köhler B
Eur J Endocrinol; 2012 Jul; 167(1):125-30. PubMed ID: 22474171
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of five NR5A1 gene mutations found in patients with 46,XY disorders of sex development.
Fabbri-Scallet H; de Mello MP; Guerra-Júnior G; Maciel-Guerra AT; de Andrade JGR; de Queiroz CMC; Monlleó IL; Struve D; Hiort O; Werner R
Hum Mutat; 2018 Jan; 39(1):114-123. PubMed ID: 29027717
[TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of NR5A1 encoding steroidogenic factor 1 in 77 patients with 46, XY disorders of sex development (DSD) including hypospadias.
Allali S; Muller JB; Brauner R; Lourenço D; Boudjenah R; Karageorgou V; Trivin C; Lottmann H; Lortat-Jacob S; Nihoul-Fékété C; De Dreuzy O; McElreavey K; Bashamboo A
PLoS One; 2011; 6(10):e24117. PubMed ID: 22028768
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the gene coding for steroidogenic factor 1 (SF1, NR5A1) in a cohort of 50 Egyptian patients with 46,XY disorders of sex development.
Tantawy S; Mazen I; Soliman H; Anwar G; Atef A; El-Gammal M; El-Kotoury A; Mekkawy M; Torky A; Rudolf A; Schrumpf P; Grüters A; Krude H; Dumargne MC; Astudillo R; Bashamboo A; Biebermann H; Köhler B
Eur J Endocrinol; 2014 May; 170(5):759-67. PubMed ID: 24591553
[TBL] [Abstract][Full Text] [Related]
9. Ten novel mutations in the NR5A1 gene cause disordered sex development in 46,XY and ovarian insufficiency in 46,XX individuals.
Camats N; Pandey AV; Fernández-Cancio M; Andaluz P; Janner M; Torán N; Moreno F; Bereket A; Akcay T; García-García E; Muñoz MT; Gracia R; Nistal M; Castaño L; Mullis PE; Carrascosa A; Audí L; Flück CE
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1294-306. PubMed ID: 22549935
[TBL] [Abstract][Full Text] [Related]
10. A report of two novel NR5A1 mutation families: possible clinical phenotype of psychiatric symptoms of anxiety and/or depression.
Suwanai AS; Ishii T; Haruna H; Yamataka A; Narumi S; Fukuzawa R; Ogata T; Hasegawa T
Clin Endocrinol (Oxf); 2013 Jun; 78(6):957-65. PubMed ID: 23095176
[TBL] [Abstract][Full Text] [Related]
11. Novel NR5A1 Pathogenic Variants Cause Phenotypic Heterogeneity in 46,XY Disorders of Sex Development.
Sudhakar DVS; Jaishankar S; Regur P; Kumar U; Singh R; Kabilan U; Namduri S; Dhyani J; Gupta NJ; Chakravarthy B; Vaman K; Shabir I; Khadgawat R; Deenadayal M; Chaitanya A D; Dada R; Sharma Y; Anand A; Thangaraj K
Sex Dev; 2019; 13(4):178-186. PubMed ID: 32008008
[TBL] [Abstract][Full Text] [Related]
12. A novel heterozygous mutation of steroidogenic factor-1 (SF-1/Ad4BP) gene (NR5A1) in a 46, XY disorders of sex development (DSD) patient without adrenal failure.
Tajima T; Fujiwara F; Fujieda K
Endocr J; 2009; 56(4):619-24. PubMed ID: 19318730
[TBL] [Abstract][Full Text] [Related]
13. Mutation update for the NR5A1 gene involved in DSD and infertility.
Fabbri-Scallet H; de Sousa LM; Maciel-Guerra AT; Guerra-Júnior G; de Mello MP
Hum Mutat; 2020 Jan; 41(1):58-68. PubMed ID: 31513305
[TBL] [Abstract][Full Text] [Related]
14. Mutations in NR5A1 associated with ovarian insufficiency.
Lourenço D; Brauner R; Lin L; De Perdigo A; Weryha G; Muresan M; Boudjenah R; Guerra-Junior G; Maciel-Guerra AT; Achermann JC; McElreavey K; Bashamboo A
N Engl J Med; 2009 Mar; 360(12):1200-10. PubMed ID: 19246354
[TBL] [Abstract][Full Text] [Related]
15. Three new SF-1 (NR5A1) gene mutations in two unrelated families with multiple affected members: within-family variability in 46,XY subjects and low ovarian reserve in fertile 46,XX subjects.
Warman DM; Costanzo M; Marino R; Berensztein E; Galeano J; Ramirez PC; Saraco N; Baquedano MS; Ciaccio M; Guercio G; Chaler E; Maceiras M; Lazzatti JM; Bailez M; Rivarola MA; Belgorosky A
Horm Res Paediatr; 2011; 75(1):70-7. PubMed ID: 20861607
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal hormonal evaluation in a patient with disorder of sexual development, 46,XY karyotype and one NR5A1 mutation.
Pedace L; Laino L; Preziosi N; Valentini MS; Scommegna S; Rapone AM; Guarino N; Boscherini B; De Bernardo C; Marrocco G; Majore S; Grammatico P
Am J Med Genet A; 2014 Nov; 164A(11):2938-46. PubMed ID: 25160005
[TBL] [Abstract][Full Text] [Related]
17. Mutational and functional studies on NR5A1 gene in 46,XY disorders of sex development: identification of six novel loss of function mutations.
Rocca MS; Ortolano R; Menabò S; Baronio F; Cassio A; Russo G; Balsamo A; Ferlin A; Baldazzi L
Fertil Steril; 2018 Jun; 109(6):1105-1113. PubMed ID: 29935645
[TBL] [Abstract][Full Text] [Related]
18. Five novel mutations in steroidogenic factor 1 (SF1, NR5A1) in 46,XY patients with severe underandrogenization but without adrenal insufficiency.
Köhler B; Lin L; Ferraz-de-Souza B; Wieacker P; Heidemann P; Schröder V; Biebermann H; Schnabel D; Grüters A; Achermann JC
Hum Mutat; 2008 Jan; 29(1):59-64. PubMed ID: 17694559
[TBL] [Abstract][Full Text] [Related]
19. A novel NR5A1 variant in an infant with elevated testosterone from an Australasian cohort of 46,XY patients with disorders of sex development.
Wu JY; McGown IN; Lin L; Achermann JC; Harris M; Cowley DM; Aftimos S; Neville KA; Choong CS; Cotterill AM
Clin Endocrinol (Oxf); 2013 Apr; 78(4):545-50. PubMed ID: 22909003
[TBL] [Abstract][Full Text] [Related]
20. Novel Heterozygous Mutations of NR5A1 and Their Functional Characteristics in Patients with 46,XY Disorders of Sex Development without Adrenal Insufficiency.
Woo KH; Cheon B; Kim JH; Cho J; Kim GH; Yoo HW; Choi JH
Horm Res Paediatr; 2015; 84(2):116-23. PubMed ID: 26139438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
